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Anaphylaxis after Topical Application of
Bacitracin: A Case Report
Mona Al-Ahmad, Sean Mace, University of Toronto,
Toronto, ON 
Introduction: We present a case of anaphylaxis fol-
lowing repeated application of bacitracin. Method: A
case report of a twenty-three year old woman with no
prior allergic history who underwent body piercing of
the navel. A low grade local infection developed at
the site and this was treated intermittently over a period
of weeks with topical bacitracin (Baciguent). Follow-
ing one application she experienced rapid onset of pru-
ritus of the head and hands, generalized urticaria, dys-
pnea, wheeze and dizziness. She was successfully
treated in hospital for anaphylaxis and released. Results:
Skin prick testing with bacitracin yielded a 25 millimetre
wheal with pseudopods. Testing of bacitracin on a con-
trol subject was negative. Conclusion: Body-piercing
is a common cosmetic procedure. Localized infection
at the site of piercing is a common complication.
Repeated application of a potentially sensitizing agent
to an area of inflamed skin enhances the potential for
the development of sensitization. Bacitracin is a topi-
cal antibiotic with the capability of inducing anaphy-
lactic sensitivity following topical application. In a
survey of body-piercing establishments in Toronto,
75% recommended the use of over-the-counter topical
antibiotics such as Bactrim or bacitracin to treat local-
ized infections after piercing. The use of bacitracin at
sites of inflamed body piercings poses a risk for the
development of anaphylactic sensitivity. A history of
bacitracin use should be determined in patients with
body piercings who develop anaphylaxis.
Regulation in Expression of the High Affinity 
IgE Receptor (FcRI) in Human Neutrophils
M.P. Alphonse, L. Yu, F.E.R. Simons, K.T. HayGlass,
A. Soussi-Gounni, Departments of Immunology, 
Pediatrics/Child Health, and Medical Microbiology,
University of Manitoba, Winnipeg, MB
Introduction: The expression of high affinity receptor
for IgE, FcRI is central for allergy and asthma. Previ-
ously we have shown that human neutrophils from
asthmatics express FcRI. In this study we investigated
various factors that influence its regulation. Methods:
Peripheral blood neutrophils were isolated from adult
atopic asthmatics (n = 17), atopic non asthmatics 
(n = 15) and non-allergic donors (n = 16) by dextran,
ficoll gradient centrifugation and magnetic cell sorting
(MACS). Surface, total protein and mRNA expression
of FcRI was investigated in the three groups by FACS,
immunocytochemistry (ICC) and fluorescent in situ
hybridization (FISH) respectively during the pollen
allergic and outside the pollen season. Furthermore,
neutrophils from atopic asthmatic subjects were
stimulated in vitro with Th-2 cytokines (IL-4, IL-9,
GM-CSF). Surface, total protein and mRNA expression
of FcRI by neutrophils was evaluated by FACS, West-
ern blot, real-time PCR and FISH. Results: Neutrophils
from atopic asthmatic subjects showed increased expres-
sion of FcRI chain in surface, total protein and mRNA
compared to atopic non asthmatics and non-allergic
donors (n = 20). In contrast to healthy donors and atopic
non asthmatics (n = 8), FcRI chain surface and
mRNA expression increased significantly during pollen
season compared to non pollen season (p = .001) in
neutrophils isolated from AA (n = 9). Interestingly, 
Th2 cytokines (IL-4, IL-9, GM-CSF) stimulated neutro-
phils (n = 6) at 6 and 18 hrs showed increased protein
and mRNA expression of FcRI  chain as assessed by
FACS, Western blot, real time PCR, and FISH analy-
sis. Conclusion: Our data suggest that the expression of
FcRI in neutrophils of atopic asthmatic patients is reg-
ulated in vivo. Furthermore it provides evidence that Th-
2 cytokines such as IL-9, IL-4 and GM-CSF regulate
the expression of FcRI in neutrophils. Collectively
neutrophil mediated FcRI dependent activation may
play a key role in allergic diseases.
Follow-up of Peanut Allergic Patients 
with Serum Peanut Specific IgE
R. Borici-Mazi, J.A. Mazza, D.W. Moote, K. Payton, M.
Zeale, Division of Allergy and Clinical Immunology,
Department of Medicine and Laboratory of Immunol-
ogy at London Health Sciences Centre, London, ON
Background: Peanut allergy is not necessarily a lifelong
problem. DBPCFCs (double-blinded placebo-con-
trolled food challenges) are “gold standard” in diag-
nosing peanut allergy. In practice, peanut specific IgE
(PN-IgE) are used to predict symptomatic allergy and
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tolerance, and reduce the number of DBPCFCs. Cur-
rent practice guideline is to do yearly measurement of
PN-IgE. Objective: The goal of this study was to deter-
mine the optimal frequency of PN-IgE measurement as
part of screening for development of clinical tolerance
to ingested peanuts. Method: Retrospective review of
charts of peanut allergic patients followed up and seri-
ally tested for PN-IgE with a quantitative antibody
fluorescent-enzyme immunoassay at Laboratory of
Immunology LHSC, from 1997-present. Statistics:
Time to first decline of PN-IgE values was estimated
using Kaplan-Meier technique. Group comparisons
were made using log-rank statistics. P values less than
.05 were considered statistically significant. Results: A
total of 782 patients evaluated for food allergy were
reviewed. Of those, 101 patients with peanut allergy ful-
filled the study criteria (age at first reaction 6 mos-15
yrs old, median 1.5 yrs old; initial PN-IgE 0.4 - > 100
kUA/L, median 18.5 kUA/L). 12% and 63% of all
patients achieved significant decrease in PN-IgE val-
ues after 2 and 5 years, respectively (median time was
41.7 months). Younger age (< 2 years old) at first reac-
tion and first PN- IgE measurement predicted longer
recovery time for PN-IgE (p = .002 and p = .016,
respectively). At 2 years interval, 14.8%, 15.35% and
3.9% of patients with baseline values < 17.5 kUA/L,
17.5-100 kUA/L and > 100 kUA/L respectively, had a
significant decrease of  PN-IgE values, whereas 5 year
reduction rate was 49.69% and 80.4% of patients with
baseline PN-IgE < 17.5 kUA/L and 17.5-100 kUA/L,
respectively. Moreover, reduction rate of PN-IgE was
determined by baseline values (p = .035). Conclusions:
This study suggests that PN-IgE values can be measured
at least every 5 years in order to predict the degree of
tolerance and the results of DPCFCs. The decision to
repeat PN-IgE varies upon the initial PN-IgE value. This
study provides evidence for a possible new practice
guideline for following up patients evaluated for peanut
allergy.
The Intensity of Recall Cytokine Responses 
to Respiratory Viruses Associated 
with Allergic Status 
R. Douville, Y. Li, N. Bastien, K. Coombs, F.E.R.
Simons, K.T. HayGlass, CIHR National Training
Program in Allergy and Asthma Research; Depart-
ments of Immunology, Medical Microbiology, and
Pediatrics/Child Health, University of Manitoba; Cana-
dian Science Centre for Human and Animal Health,
Winnipeg, MB
Respiratory syncytial virus, metapneumovirus (MPV)
and reovirus are RNA viruses that commonly infect
humans. RSV and MPV have an apparent association
with asthma exacerbations. We hypothesized that these
ubiquitous viruses elicit potent recall responses dom-
inated by Th1-biased cytokine production, and that
the intensity of such recall cytokine responses associ-
ates with clinical status. We established short-term pri-
mary culture systems using peripheral blood mononu-
clear cells (PBMC) from adults to evaluate (i) the
prevalence of virus-specific cytokine recall responses,
(ii) virus-induced cytokine producing cell subsets, (iii)
to test the hypothesis that different recall responses are
evident to respiratory viruses in mildly asthmatic ver-
sus non-atopic humans. Fresh PBMC from > 60 indi-
viduals were isolated and cultured with live virus.
Supernatants were harvested 1-6 days later, with the fre-
quency and intensity of type 1 (IFN

), type 2 (IL-13,
IL-5) and IL-10 virus-specific responses quantified by
ELISA. Virus-specific IFN was dependent on classi-
cal T cell activation, as demonstrated by costimulatory




in asthmatic and allergic individuals compared to non-
atopics (p < .001). These differences were not appar-
ent in MPV and RSV-specific IFN

responses. In sum-
mary, these respiratory viruses provide a powerful
model for examination of the impact of viral infections
in modulating established human immune responses to
environmental allergens. Support: CIHR, Canada
Research Chair in Immune Regulation, Tom and Min-
del Olenick Award in Immunology, Manitoba Health
Research Council.
VAMP-7 and VAMP-2 Are Potential Partners for
Syntaxin-4 and SNAP-23 during Exocytosis in
Human Basophils and Mast Cell
R. Dyatlova, D. Befus, R. Moqbel, Pulmonary Research
Group, University of Alberta, Edmonton, AB
Background: Mast cells and basophils, critically impor-
tant granulocytes in allergic reactions and asthma, syn-
thesize and secrete a wide variety of proinflammatory
mediators. Products such as vasoactive amines, pro-
teases, cytokines and chemokines are thought to con-
tribute to tissue injury and remodeling. Different iso-
forms of SNARE (soluble NSF attachment protein
receptors) proteins have been implicated in regulation
granule and vesicule docking during exocytosis by
some leukocytes. However, little is known about the
mechanism(s) leading to membrane docking and fusion
in basophils. Objective: We investigated the expression
of SNARE proteins using both peripheral blood-derived
human basophils and a basophilic cell line, KU-812.
We compared our findings with SNARE profiles from
two mast cell lines: human mast cell-1 (HMC-1) and
the  Laboratory of Allergic Diseases-2 (LAD-2). Meth-
ods: Highly purified human peripheral blood basophils
(≥ 96%) from atopic subjects were obtained by nega-
tive immunomagnetic selection. Total nucleic acid
(RNA) was extracted and subjected to RT-PCR. West-
ern blot analysis and confocal microscopy were also
used to identify protein expression and distribution of
distinct isoforms of SNARE complex. Results: Human
basophils (n = 5) expressed mRNA for the v-SNARE
isoforms, VAMP (vesicle-associated membrane pro-
tein)-1, -2, -3, -7 and -8 and the t-SNAREs SNAP-23
and syntaxin -3, -4 and -6. KU-812, HMC-1 and LAD-
2 shared the same SNARE phenotype profile with
those in human basophils. Syntaxin-3, -4, -6 and SNAP-
23 and VAMP-7, VAMP-8 were also identified at the
protein level using Western blot analysis of human
basophils. Confocal imaging showed the substantial co-
localization of v-SNARE, VAMP-2 and VAMP-7 with
CD-63 (granular marker). Conclusions: Our findings
suggest that human basophils express SNARE iso-
forms necessary for docking of their granules and
secretory vesicles during exocytotic processes leading
to mediator secretion.
The Incidence of Drug Hypersensitivity 
and Idiosyncrasy as a Presenting Problem 
to an Emergency Department
Anne K. Ellis, Queen’s University, Kingston, ON
Background: The community incidence of allergic
reactivity to medications is varied, but known to be less
than that observed in inpatient populations. Outpatient
rates of 0.06%, 0.13%, and 0.30% have been reported
from Australia, Italy, and the U.S., respectively. Objec-
tive: To describe the outpatient epidemiology of drug
hypersensitivity occurring in a tertiary care center in
Canada. Methods: Three years of emergency department
(ED) charts were reviewed. All ED visits given a dis-
charge diagnosis of “allergic reaction” or “anaphylaxis”
were pulled and directed to the investigator. Chart
review and direct patient contact determined if crite-
ria for these diagnoses were properly met. Results:
Over the 3-year time period, 153,990 patients were
assessed in the ED at KGH. A total of 554 cases of
“allergic reactions” (including anaphylaxis) were iden-
tified. Of these, 111 were labeled secondary to med-
ications. Further chart review reduced this number to
101 reactions that could be classified as either allergic
or idiosyncratic (pseudo-allergy). This yielded a 0.07%
incidence of drug hypersensitivity/idiosyncrasy as a pre-
senting problem. 22 (21.8%) of the reactions were ana-
phylactic in nature, 3 required admission to hospital,
there were no fatalities. Antibiotics were the most com-
monly implicated medication, accounting for 57 (56.4%)
of all reactions. Of the antibiotics, penicillins (21),
macrolides (11) and sulfonamides (9) were most fre-
quently involved. NSAID idiosyncrasy accounted for
15 (14.9%) of the reactions. Opiates followed with 
8 (7.9%). Conclusion: Drug hypersensitivity/idiosyn-
crasy is an important presenting problem to emergency
departments in Canada and elsewhere. The incidence
in this study was 0.07%, mostly to antibiotics. This study
was internally funded. The author would like to
acknowledge Dr. James Day for his editorial review of
this abstract.
Delayed Hypersensitivity to Titanium 
Causing Pacemaker Allergy
Anne K. Ellis, Peter Hollett, Chris Simpson, James Bren-
nan, James H. Day, Queen’s University, Kingston, ON
Background: Component allergy is an extremely
rare, but documented complication of pacemaker
insertion. Case: A 33-y-old male with a 28-y history
of pacemaker dependence presented to cardiology
complaining of pain and redness at his pacemaker site.
He had a history of recurrent pocket site infections
leading to the replacement of multiple transthoracic,
and later transvenous pacing systems, the most recent
having been inserted 3 years ago. He also had a his-
tory of atopy including anaphylaxis to latex, kiwi, and
methylparaben. Approximately 2 months prior, he
developed tenderness, swelling and redness overly-
ing his pacer site. Examination revealed erythema and
minimal edema, but no localized heat. He was afebrile.
Multiple blood cultures were negative. No pace-
maker pocket fluid or other abnormalities were iden-
tified with ultrasound or computed-tomography scan-
ning. A 5-day course of prednisone produced partial
relief, but symptoms recurred. Empiric courses of
ciprofloxacin and carbamazepine yielded no response.
He ultimately required admission to hospital 5 months
into his illness for intravenous opiates to achieve
pain control. Repeat investigations were unremark-
able, including an ESR of 1 mm/hr. Antibiotics were
discontinued with no worsening of symptoms. An
allergy consultation led to patch testing to the four
components of the device (titanium, polyurethane, sil-
icone, and polyurethane insulation) resulting in a
positive reaction to titanium only. Titanium patch
testing on a non-allergic control subject was negative.
The patient was diagnosed with delayed hypersensi-
tivity to the titanium-coated pacemaker. His pace-
maker was removed and a gold-coated replacement
system was inserted. Cultures from the original pacer
were negative. The patient has done well subse-
quently, having no evidence of reactivity at the site.
Conclusion: Delayed hypersensitivity to titanium-
coated pacemakers can result in chronic localized
inflammation and apparent recurrent infections at
the site of implantation which can be misleading.
Persistent reactivity at the site of pacer implantation
is reason to suspect this rare condition.
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Medicine Wheel Navigates Sage Journey
Donna Everette, Section of Allergy, Asthma and Clini-
cal Immunology, University of Manitoba, Winnipeg, MB
SAGE, funded by CIHR, is a Manitoba Institute of Child
Health, University of Manitoba project designed to
Study in Asthma the role of Genes and the Environment
in the 1995 Manitoba birth cohort. One thousand chil-
dren and their families from across the province will
be enrolled in this project, 200 children from rural
Manitoba, 200 from First Nation’s communities. The
First Nation’s children have a high incidence of respi-
ratory disease (not necessarily asthma) and provide a
unique opportunity to study a genetically diverse pop-
ulation living in both developed and developing world
environments. The Medicine Wheel is used as the nav-
igation tool to achieve a balance in the overall process
from both parties involved in the SAGE project. First
Quadrant of the Medicine Wheel emphasizes the inher-
ent rights as First Nations people before and after colo-
nialism and colonization and secondly, how First
Nations connect the ownership in relation to research.
Second Quadrant focuses on the importance and sig-
nificance of the First Nation people’s autonomy and tak-
ing control of their lives in all aspects: physically,
emotionally, mentally and spiritually and secondly,
how First Nations can relate to control in relation to
research data and reports. Third Quadrant shares the
SAGE journey and its correlation of a personal jour-
ney centered on trust and openness. The gaps and
strengths of SAGE are shared and the ways on how the
whole process was navigated. Fourth Quadrant teaches
the importance of involving the whole community
from the children, youth, adults, and the elders. The
appropriate research practices on partnership build-
ing, developing linkages and the decision-making prac-
tices are included to stress unity and equality.
TH2 Involvement in Peanut Antigen-Specific
Responses: Comparison between Adult and
Juvenile Populations
Sherry Hebert, Tina Thottingal, F. Estelle Simons,
Allan B. Becker, A. Wesley Burks,  Kent T. HayGlass,
CIHR National Training Program in Allergy and
Asthma Research, Departments of Immunology and
Pediatrics/Child Health, University of Manitoba, Win-
nipeg, MB; Department of Pediatrics, Duke University,
Raleigh, NC
Peanut allergy is one of the most severe food allergies,
representing an important cause of food induced ana-
phylaxis or fatality. While extensive investigation has
been made of allergen structure and the nature of anti-
body recognition of peanut allergens, little is known
about the role played by T cells in the maintenance of
tolerance vs allergy to peanut. Here, we developed
systems to examine human peanut allergen specific 
T cell cytokine responses and investigate differences
between (i) peanut allergic, (ii) peanut sensitized (skin
test positive but clinically non-atopic) and (iii) peanut
non-sensitized individuals. Using a primary culture
system we developed in which freshly isolated human
PBMC are stimulated with whole peanut allergen
extract, we compared patterns of responsiveness 
in adults (60 adults, 18-40 years old) and children 
(40 8-9 year olds) by assessing the frequency and
nature of responses characteristic of Th1-like (IFN,
CXCL10) and Th2-like (IL-5, IL-13, CCL17, CCL22)
recall responses to peanut allergen. Among adults, we
found that peanut specific Th2 responses were readily
demonstrable in ~ 50% of non-atopic/non-sensitized
individuals and 90% of sensitized (but clinically unre-
sponsive) subjects. These were CD4 T cell dependent
and required classical T cell activation as demonstrated
by the capacity of HLA-DR, CD80/86 or CTLA4-
Ig to block recall responses. In contrast, IFN and
CXCL10 responses were rarely seen. Thus, analysis of
CD4 T cell dependent allergen specific responses
demonstrates that (i) a substantial proportion of clini-
cally asymptomatic humans exhibit immune responses
to this common food antigen, enabling us to investigate
the mechanisms underlying the maintenance of food
allergy and (ii) Th1-like responses, characteristic of pro-
tection from allergic disease to inhalant allergens, are
extremely rare. Current studies are aimed at deter-
mining the contributions such immunity plays in shap-
ing the food allergy vs tolerance decision. Support:
CIHR, NSERC Studentship, Manitoba Institute for




Amin S. Kanani, Division of Allergy and Clinical
Immunology, St. Paul’s Hospital, University of British
Columbia, Vancouver, BC
A50-year-old gentleman presented with class III NYHA
heart failure associated with malaise and low-grade
fever. He had increased migraine headaches in the pre-
ceeding one month. During this period he was taking
sumatriptan (Imitrex) for approximately 4 days per
week and ibuprofen daily. He denied taking other med-
ications. He did not have any recent travels. He does
not have a history of asthma or sinusitis. His physical
examination was consistent with congestive heart fail-
ure. There were no rashes. The ECG showed changes
suggestive of ischemia. There was a mild rise in troponin
level. White blood cell count was elevated at 15.1 g/L
(4.0-11.0 g/L) with increased neutrophils at 13.4 g/L
(2.3-7.7 g/L). Peripheral eosinophil count was 0. Blood
work from 4 weeks prior to presentation indicated a
normal WBC with 0 eosinophils. Blood tests were
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negative for ANA, rheumatoid factor, ANCA, cryo-
globulins, HIV serology, and hepatitis B serology. CT
scan of the head was normal and CSF analysis was nor-
mal. Echocardiogram showed left ventricular hyper-
trophy and an ejection fraction of 45%. Coronary
angiography revealed normal coronary arteries.
Endomyocardial biopsy revealed necrotizing myocardi-
tis with prominent eosinophil infiltrate. The sumatrip-
tan and non-steroidal anti-inflammatory drugs were
discontinued. He was started on prednisone 60 mg
daily which after 2 months was tapered down to 15 mg
daily. He was also initially treated with furosemide,
ramipril and carvedilol. Echocardiogram 3 months
after initial presentation showed a normal ejection frac-
tion. The furosemide and ramipril were discontinued.
Peripheral eosinophil count has remained normal. This
is a unique case of eosinophilic myocarditis poten-
tially associated with sumatriptan and/or non-steroidal
anti-inflammatory drugs.
Socioeconomic Status 
and the Development of Asthma
A.L. Kozyrskyj, A.B. Becker, Faculty of Pharmacy
and Faculty of Medicine, University of Manitoba,
Winnipeg, MB
The association between low socioeconomic status
and asthma is inconsistent, and not compatible with the
hygiene hypothesis. We undertook this research to
determine the relationship between socioeconomic sta-
tus and the development of asthma, and to identify
environmental factors that may explain this relationship.
In 2002/03, a survey was sent to 12,556 households of
children born in Manitoba in 1995, asking parents
whether they or their 7-year old child had asthma, and
whether smokers or pets were present in the birth
home. Survey responses were linked to health care
records for lower respiratory tract infections (LRI)
during infancy, and to a census-based measure of
income. The likelihood (odds ratio, OR) of asthma
was determined according to income, and exposure to
tobacco smoke, pets and LRI within the first year of life.
3,564 (28.4%) of the surveys were returned. Parents
reported asthma in 12% of children living in urban
areas. Asthma prevalence declined progressively by
income area from 17% to 11% in the highest income
neighbourhoods. Asthma prevalence was not related to
income in rural areas. Lower income, urban children
were more likely to be exposed to tobacco smoke, cats
and LRI during infancy. In comparison to high income,
urban children, the odds ratio for asthma in low and mid-
dle income children was 1.74 (95% CI: 1.07–2.83)
and 1.32 (95% CI: 0.98–1.78), respectively. The
increased likelihood of asthma in lower income children
was independent of family history of asthma/allergy
(OR = 3.93, 95% CI: 2.93–5.28) and of exposure to LRI
in infancy (OR = 3.29, 95% CI: 1.37–7.88). The income-
asthma association in urban children was not diminished
by early childhood exposure to tobacco smoke, cats or
dogs. An inverse association between the development
of asthma and socioeconomic status was only observed
in Manitoba children living in urban areas. This asso-
ciation was not explained by early exposure to house-
hold allergens.
The Natural History of Wheezing Syndromes 
in Pre-Term Children
J.J. Liem, A.L. Kozyrskyj, A.B. Becker
Rationale: To describe the natural history of wheezing
syndromes in premature/low birthweight babies com-
pared to term/normal birthweight babies. Methods:
The Manitoba Health Services Insurance Plan (MHSIP)
database is a population-based, health care adminis-
trative and prescription database. It has records of
every child born in 1995 and subsequent utilization of
the provincial health care system. The number of chil-
dren diagnosed with a wheezing syndrome (defined as
an ICD-9 code of 493 [asthma diagnosis for hospital-
ization or physician visit] or a prescription of an asthma
medication) was obtained. The relative risks (RRs) of
wheezing in premature/low birthweight children com-
pared to term/normal birthweight were determined up
to 7 years of age. Results: 13,980 children were born
in 1995 and are currently living in the province of
Manitoba. In comparison to term infants (37–42 weeks
gestational age [GA]), the RRs of a wheezing syn-
drome in infants born < 28 weeks GA (n = 45) at 1, 3,
5, and 7 years were 1.76*, 1.44, 1.75* and 1.30. RRs
for 28–32 weeks GA (n = 84) were 1.72*, 2.39*, 2.26*
and 1.25* and for 32–37 weeks GA (n = 763), RRs were
1.17*, 1.14, 1.14, and 1.25* at 1, 3, 5, and 7 years. In
comparison to normal birthweight infants (2,500-4,500
g), the RRs of a wheezing syndrome in infants born 
< 1,000 g (n = 37) at 1, 3, 5, and 7 years were 2.25*,
2.12*, 2.14* and 1.35. In babies with birthweights
between 1,000–1,500 g (n = 70), RRs were 1.52*,
1.94*, 1.92* and 1.55 at 1, 3, 5, and 7 years. Conclusion:
Babies born at low gestational ages and with low birth-
weights have an increased risk of a wheezing syn-
drome in the first seven years of life.
*Denotes statistical significance.
Cytokine Responses to Toll-Like Receptor
Stimulation in Children
Yuriy Lissitsyn, Allan B. Becker, Kent T. HayGlass,
Departments of Immunology and Pediatrics/Child
Health, University of Manitoba, Winnipeg, MB
Introduction: Activation of Toll-like receptors (TLRs)
by distinct microbial ligands triggers not only innate
immunity, but also regulates the nature of the adaptive
immune response, and thus may influence either devel-
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opment of, or exacerbation of, allergic diseases such as
asthma. The role of TLR responsiveness in human
asthma remains unknown. We hypothesize that func-
tional responsiveness to TLR stimulation by physio-
logically relevant ligands differs in asthmatic and
healthy control children. The specific objective of this
study has been (i) to identify “optimal” and “threshold”
doses of a panel of relevant TLR ligands and (ii) to deter-
mine optimal experimental conditions for quantitative
analysis of patterns of cytokine and chemokine
responses. Methods: PBMC obtained from ~ 200 8-9
year old children were stimulated with distinct TLR lig-
ands: lipopolysaccharide, peptidoglycan, 3M-011 com-
pound or poly(I:C) at concentrations over five log
range for 24 h. This time point was chosen on the basis
of kinetic studies. Absence of endotoxin contamination
was verified by LAL assay. Levels of cytokines and
chemokines produced by these children were mea-
sured by ELISA. Results: All individuals studied
responded to these TLR ligands. The “optimal” and
“threshold” conditions were identified. Specifically,
lipopolysaccharide and peptidoglycan have the ability
to stimulate production of cytokines (IL-6, TNF-,
IL-1∃, IL-12p40, IL-10) and chemokines (CCL2,
CCL22) in a dose dependent manner. 3M-011 elicits a
similar pattern of cytokine responses and induces sig-
nificant levels of IFN- and CXCL10. Stimulation
with poly(I:C) resulted in production of IFN- and
CCL2; levels of other tested cytokines and chemokines
were below the limit of detection for these ligands.
Conclusion: Lipopolysaccharide, a TLR4 ligand, pep-
tidoglycan, a TLR2 ligand, 3M-011, a TLR7 ligand, are
potent stimuli of cytokine and chemokine production
by PBMC derived from children. Poly(I:C), a TLR3 lig-
and, induced production of IFN- and CCL2, but few
other cytokines. “Optimal” and “threshold” stimulation
concentrations of lipopolysaccharide, peptidoglycan,
3M-011 and poly(I:C) were identified that will be used
to test the main hypothesis upon unblinding of the
study. Research support: SAGE, Canadian Institutes of
Health Research, CRC Chair Program.
Peptide-Based Vaccines 
against Human Interleukin-13 (hIL-13)
Yanbing Ma, Qingliang Liu, Tingting Zhang, Kent Hay-
Glass, Allan Becker, Zhikang Peng, Department of
Pediatrics and Child Health and Department of
Immunology, University of Manitoba, Winnipeg, MB
IL-13 is one of the key contributors in allergic asthma.
It promotes IgE class switching and in the lung upreg-
ulates eosinophilic inflammation, mucus secretion, and
airway hyperresponsiveness. Immunologically down-
regulating the level of IL-13 may be a better approach
for asthma treatment than the current pharmaceutical
therapies. This is supported by the successful admin-
istration of humanized monoclonal antibodies to IgE
as passive immunotherapy in asthma treatment. How-
ever, a short half-life and extremely high cost limit the
use of this approach. To overcome these disadvan-
tages, we aimed to develop active immunotherapy
using an anti-hIL-13 vaccine which induced auto-neu-
tralizing antibodies to hIL-13. The vaccine conjugate
consisted of a hIL-13 peptide (12-17 amino acid
residues) derived from hIL-13 receptor binding sites,
made immunogenic by linking it to a foreign carrier pro-
tein via two approaches. (1) Chemical methods: syn-
thesized peptides were coupled to bovine serum albu-
min (BSA) using the glutaraldehyde method; (2)
molecular engineering: the peptide was fused to the
hepatitis B core antigen (HBcAg) to form chimeric
HBcAg. Three chemically coupled conjugates and one
chimeric HBcAg that presents as capsule-like particles
were tested in mice. Mice were immunized three times
with a vaccine conjugate emulsified in an adjuvant.
Immunization with the carrier BSA or natural HBcAg
served as controls. Sera were collected two weeks after
the last immunization. Titres to hIL-13 were measured
by an ELISA. Two vaccine conjugates and the chimeric
HBcAg were found to elicit high titres of antibodies to
hIL-13. Inhibition tests revealed that these vaccinated
sera inhibited the binding of hIL-13 to its receptors in
a dose-dependent manner using receptor-capture ELISA
and hIL-13- induced B cell proliferation tests, sug-
gesting that vaccine-induced antibodies are able to
inactive hIL-13 in vitro. Studies of the in vivo effect
of the vaccine are currently in progress in a mouse model
of asthma. This study was supported by The Hospital
for Sick Children Foundation (Toronto) and the Chil-
dren’s Hospital Foundation of Manitoba Inc.
Is There an Association between Childhood
Immunizations and Childhood Asthma?
Kara McDonald, Department of Community Health
Sciences, University of Manitoba, Winnipeg, MB
Background: The prevalence of childhood asthma has
steadily increased over the past two decades. This is of
great concern as the implications of this have been
huge both socially and economically (direct and indi-
rect costs). There are many theories as to why there has
been such an increase in asthma and allergies in the
developed world. One such theory is the Hygiene
Hypothesis. This particular theory has provided the
background for my current research. It states that our
immune systems have not been able to adapt quickly
enough to the rapidly occurring changes in our living
environments (improved sanitation, new and improved
antibiotics and immunizations). Thus, these changes
have made it much easier for our immune systems to
slip into unbalanced states where allergies and asthma
can arise.1 Methods: My thesis is a retrospective birth
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cohort of Manitoba children born in 1995. My outcome
of “asthma” has been validated by Dr. Anita Kozyrskyj
and Dr. Allen Becker in their NET study. I have been
linking immunization data from the Manitoba Immu-
nization Monitoring System (MIMS) to other admin-
istrative data such as drug, medical and hospital data
using SAS (Statistical Analyses Software). I am par-
ticularly interested with the diphtheria combination
vaccines (both cellular and acellular), the
measles/mumps/rubella (MMR), as well as the BCG
vaccine. I am analyzing the types of vaccines which are
given, the time frame in which they are given, the chil-
dren’s immunization status, and their possible associ-
ation with asthma. Results: My results and the statis-
tical relevance of my findings have yet to be completed.
However, as an example of my preliminary findings on
the 13, 980 children in the cohort I have found the fol-
lowing: 1, 569 of the children have been determined
to have asthma at age 7 with the onset varying from 0
to 7 years of age. Only 416 children were vaccinated
with BCG, of which 33 had asthma (7.93%) compared
to an asthma rate of 11.32% in the rest of the popula-
tion. Of the children in the cohort 97.5% of them had
had one or more MMR vaccines, while only 110 chil-
dren or 0.79% had never received any immunizations.
Conclusion: It is premature to state my final conclu-
sions for the specific questions raised in my thesis.
However, regardless of the final outcome I believe
that this research is timely and will be of value to the
scientific community.
Human Eosinophils Constitutively 
Express Indoleamine 2,3-Dioxygenase 
and Regulate T-Cell Function
S.O. Odemuyiwa, A.G. Ghahary, Y. Li, L. Puttagunta,
A. Ghahary, R. Moqbel, Pulmonary Research Group,
Department of Medicine, University of Alberta,
Edmonton, AB
Indoleamine 2,3-dioxygenase (IDO) catabolizes tryp-
tophan to kynurenines (KYN), which in turn inhibit pro-
liferation and survival of T cells, especially Th1. Reg-
ulatory dendritic and T-cells downregulate T-cell
function via KYN-mediated mechanisms. Eosinophils,
whose numbers increase following allergen challenge,
have the potential to interact with T-cells. We hypoth-
esized that increase in IDO-expressing eosinophils
during allergic inflammation is an immunoregulatory
mechanism in the maintenance of -Th2 polarization in
allergic inflammation. Eosinophils from atopic and
non-atopic donors were probed for IDO expression
using RT-PCR and Western blotting. The effect of IL-
3, IL-5 and GM-CSF on IDO expression was deter-
mined using quantitative PCR. KYN was measured to
determine enzymatic activity of IDO. Eosinophils were
co-cultured with IFN- or IL-4-producing T cell lines
or clones before measuring apoptosis or proliferation
of T cells. IDO expression in lung tissue of allergic sub-
jects, and in tissues from a mouse model of allergic
inflammation, was examined using immunohisto-
chemistry. Eosinophils express IDO mRNA and pro-
tein constitutively and produce KYN following IL-3,
IL-5, GM-CSF, and IFN treatment, leading to T-cell
apoptosis and inhibition of PHA-induced proliferation
of PBLs. While IL-3 reduced IFN-induced IDO
mRNA below resting levels in Eos, IL-5 induced only
a 2-fold reduction. Conversely, treatment with GM-CSF
led to a 3-fold increase in IFN-induced mRNA expres-
sion. Crosslinking of CD28 on eosinophils induced
IFN release with autocrine effects, leading to trypto-
phan catabolism to KYN. Co-culture of T cells with
eosinophils inhibited proliferation of an IFN-pro-
ducing T cell line but not an IL-4-producing T cell
clone. There was extensive infiltration of IDO-express-
ing eosinophils into lymphoid aggregates from atopic
subjects. Eosinophils were the main IDO-expressing
cells found in the lung tissues of OVA-sensitized mouse
model of allergic inflammation. Our data suggest that
eosinophils may potentially regulate T-cell function
in vivo through IDO-dependent pathways, thus con-
tributing to the maintenance of Th2 polarization char-
acteristic of atopic disease.
Interleukin-17 Modulates IL-1 Induction 
of IL-8 and IL-6 Expression in Human 
Airway Smooth Muscle Cells: 
Role in Neutrophilic Inflammation
Muhammad Shahidur Rahman, Jie Yang, LianYu Shan,
Andrew J. Halayko, Abdelilah Soussi Gounni, Depart-
ment of Immunology, Physiology and Respiratory Divi-
sion, University of Manitoba, Winnipeg, MB
Background: Airway neutrophilia is a predominant
feature of acute lung disorders such as chronic obstruc-
tive pulmonary disease (COPD) and severe asthma.
While IL-17 induced expression of the CXC
chemokines in the airways leading to neutrophil recruit-
ment is well established, potential direct effects of IL-
17 on airway smooth muscle (ASM) function have not
been determined. Aim: This study aimed to investigate
the role of IL-17R in the activation of human ASM cells
and release of inflammatory mediators. Experimental
Procedures: IL-17R mRNA and surface bound recep-
tor expression were investigated by RT-PCR and flow
cytometry. Immunofluorescence study was carried out
to detect IL-17R within bronchial smooth muscle.
ELISA and quantitative real-time PCR were carried out
to investigate the effect of IL-17 and IL-1 stimulation
on IL-8 and IL-6 mRNA and protein expression. In vitro
chemotaxis assay measured the effect of conditioned
medium of IL-17 stimulated ASM cells on the migra-
tory capacity of human neutrophils. In vivo expression
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of IL-17R in human ASM bundle within bronchial
sections of COPD patients was performed by immuno-
fluorescence coupled to confocal microscopy. Results:
ASM cells expressed steady state of IL-17R protein,
mRNA and surface bound receptor. IL-17 stimulated
IL-8 and IL-6 release from ASM cells in a time- and
dose-dependent manner that was significantly inhibited
by neutralizing anti-IL-17 mAb. Interestingly, IL-17 dra-
matically enhanced IL-1 induced expression of IL-6
and IL-8 protein and mRNA. The effect of IL-17, alone
or in combination with IL-1, was abrogated by actin-
omycin-D, suggesting that IL-17 regulates IL-6 and 
IL-8 at the transcriptional level. In vitro chemotaxis
assay showed that IL-17 induced IL-8 release from
ASM cell conditioned medium attracted neutrophils.
Finally, ASM cells bundle within human airway sec-
tions from COPD patients showed IL-17R positive
immunostaining. Conclusion: These data clearly demon-
strate that ASM cells are a target for IL-17 and suggest
that ASM cells participate via an IL-17 dependent
manner in the recruitment of inflammatory cells, par-
ticularly neutrophils, into the airway.
Syk Tyrosine Kinase Participates in 1 Integrin
Signaling and Inflammatory Responses 
in Airway Epithelial Cells
Marina Ulanova, Lakshmi Puttagunta, Marcelo Marcet-
Palacios, Florentina Duta, Moo-Kyung Kim, Alan D.
Schreiber, A. Dean Befus, Department of Medicine,
University of Alberta, Edmonton, AB; University of
Pennsylvania School of Medicine, Philadelphia, PA
The protein tyrosine kinase Syk is best known as a crit-
ical component of immunoreceptor signaling com-
plexes in hematopoietic cells. Recent studies showed
Syk expression in some nonhematopoietic cells, impli-
cating its involvement in other important cellular func-
tions. We have recently demonstrated that Syk is widely
expressed in respiratory epithelial cells (EC) in situ, as
well as in cultured primary bronchial EC and cell lines
HS-24 and BEAS-2B. We hypothesized that Syk func-
tions as a signaling molecule involved in inflammatory
responses in the epithelium. To characterize Syk expres-
sion in airway EC, immunohistochemistry, Western
blot, PCR, and laser scanning confocal microscopy
were used. Syk-dependent signaling pathways in EC
were initiated by engagement of 1 integrin recep-
tors. Stimulation of 1 integrin receptors by fibronectin
or antibody cross-linking caused redistribution of Syk
from a cytoplasmic to plasma membrane localization.
In stimulated cells, Syk and integrin 1 co-localized.
In addition, following 1 integrin receptor engage-
ment, tyrosine phosphorylation of Syk was observed.
Expression of the adhesion molecule ICAM-1 and pro-
duction of IL-6, both important molecules in lung
inflammation, was down-regulated in EC treated with
Syk small interfering RNA, or Syk inhibitor piceatan-
nol. We propose that Syk is involved in signaling path-
ways induced by integrin engagement in airway EC.
Syk-mediated signaling regulates IL-6 and ICAM-1
expression and may be important in the pathophysiol-
ogy of lung inflammation. Funded by CIHR,
CSACI/CAAIF/Merck Frosst, Alberta Heritage Foun-
dation for Medical Research, and NIH.
Anaphylactic Reaction during Intrauterine
Insemination Caused by Egg Yolk Allergy
N. Verreault, R. Gagnon, R. Kagan, J. Mailloux, P.M.
Bédard, Allergy and Clinical Immunology, Montreal
Children’s Hospital, McGill University Health Centre,
Montreal, QC; Allergy and Clinical Immunology, Cen-
tre Hospitalier Universitaire de Québec-CHUL, Quebec
City, QC; Gynecology and Obstetrics, Centre Hospitalier
Universitaire de Québec-CHUL, Quebec City, QC
Introduction: Anaphylaxis during artificial insemi-
nation usually occurs with the following allergens:
latex, human spermatic fluid, drugs added to the
sperm processing media, and the preservative bovine
serum albumin (BSA). Case History: This 27 year old
woman with allergic rhinoconjonctivitis and asthma
has had 10 attempts of artificial insemination since
1999. After each injection of thawed semen, she expe-
rienced within a few minutes severe lower abdomi-
nal pain accompanied by pallor and malaise. These
episodes were thought to be vaso-vagal reactions. On
the tenth attempt, she immediately developed gener-
alized pruritus, urticaria, angioedema, vomiting, res-
piratory distress and hypotension. After standard
emergency treatment, she recovered without compli-
cations. All artificial inseminations use sperm
processed in a solution supplemented by sterile egg
yolk. Further history revealed that the patient never
had an anaphylactic food or drug reaction. However,
during the past 5 years she could not eat raw eggs
because of a tingling sensation in her mouth and a tight
throat. She tolerates baked goods containing eggs
and cooked eggs. The skin prick tests were positive
for egg white (4 mm of induration) and egg yolk 
(8 mm), and the specific IgE level was slightly positive
(0.43 KUA/L) for egg yolk. Testing was negative for
latex and spermatic fluid. Finally, she had an unevent-
ful artificial insemination using sperm preserved with
BSA three months after the anaphylactic reaction.
Conclusion: We describe the first case of a life threat-
ening anaphylaxis in an egg allergic woman who
underwent an artificial insemination using sperm
processed in fresh egg yolk. Even if egg allergy is
extremely uncommon in adults, enquiry about food
allergies remains an important part of all medical his-
tories and particularly before prescribing injectable
medicines or biological products.
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Successful Treatment with Subcutaneous
Immunoglobulin Infusion in a Primary
Immunodeficiency Patient with Severe Adverse
Reactions to Intravenous Immunoglobulin
Joyce Yu, Nina Verrault, Ahmed Ali, Chantal Lemire,
Rhoda Kagan, Bruce Mazer, Christine McCusker, Divi-
sion of Allergy and Clinical Immunology, Montreal
Children’s Hospital, McGill University Health Centre,
Montreal, QC
Background: Intravenous immunoglobulin (IVIG) infu-
sion is an effective treatment for children with pri-
mary immunodeficiencies but it requires administration
in a hospital setting and can be complicated by systemic
reactions or poor venous access. Subcutaneous
immunoglobulin (SCIG) infusion is an alternate treat-
ment option. It is as effective as IVIG with no reported
life-threatening systemic side effects and can be admin-
istered at home. Case History: A 5 year old girl with
DiGeorge syndrome and hypogammaglobulinemia was
referred because of severe adverse reactions to IVIG.
She had features of DiGeorge including a vascular
ring, speech delay, high arched palate, distinct facial fea-
tures and combined immunodeficiency. She was pos-
itive for the chromosome 22 deletion. She had recur-
rent infections complicated by bronchiectasis, low
antibody levels and poor specific responses to her vac-
cines. She was started on IVIG. She suffered severe
headaches, vomiting, pallor and one episode of loss of
consciousness 48 hours after several of the infusions
of IVIG. Pretreatments with Benadryl, Tylenol, corti-
costeroids either immediately before or for 3 days fol-
lowing IVIG were all ineffective. Trial of different
IVIG preparations did not change frequency or sever-
ity of adverse reactions. We elected to give her a trial
of SCIG. The first infusion without any premedication
had an uneventful course. She received 10 cc of Behring
immunoglobulin (16%) solution over 1 hour given by
syringe pump into her right thigh. She developed a local
painless swelling at the injection site, which resolved
over 2 hours. She subsequently received a total of three
uneventful infusions in hospital, and then was dis-
charged to continue outpatient treatment at her local hos-
pital. Conclusion: We describe the first case in Canada
of a primary immunodeficient child with adverse reac-
tions temporally related to IVIG who tolerated treat-
ment with SCIG. This case demonstrates that SCIG is
a suitable treatment option for patients with adverse
reactions to IVIG.
Different Antigens with and without Adjuvant in
the Induction of Airway Inflammation and IgE
and IgG Responses in Mice
Tingting Zhang, Yanbing Ma, Zhikang Peng, Department
of Pediatrics and Child Health and Department of
Immunology, University of Manitoba, Winnipeg, MB
Background: Mouse models of allergic asthma with
ovalbumin (OVA) in alum have been used for many
years. However, OVA is not a common allergen to
humans and using alum for mouse sensitization is not
close to human allergic diseases. Objective: To eval-
uate the effect of different antigens and the use of nat-
ural allergens without alum in the induction of IgE and
IgG responses and airway inflammation in mice. Meth-
ods: Mice were intraperitoneal (i.p.) sensitized and
intranasal (i.n.) challenged as below: A: sensitized
twice with 2 g of OVA in alum at weeks 0 and 2 and
challenged (50 g of OVA) at week 4; B: sensitized
with 10 g of OVA twice a week for 4 weeks, and chal-
lenged at week 5; C: the same as protocol “A,” except
that OVA was replaced with 100 g of ragweed; D: the
same as protocol “B,” expect that OVA was replaced
with ragweed. Sera were obtained every 2 weeks, and
bronchoalveolar lavage fluids (BALFs) were collected
1 week after the nasal challenge. Serum total IgE,
OVA- or ragweed-specific IgE and IgG2a levels were
measured by ELISAs. BALF eosinophils were stained
and counted. Results: Mice sensitized with OVA in
alum had the highest total IgE level followed by groups
B, C and D (mean OD410 = 3.39, 2.11, 1.42, and 1.12
for groups A, B, C, and D, respectively). Antigen-
specific IgE levels were higher and specific IgG2a lev-
els were lower in groups with alum than groups with-
out alum (p < .01). There is no significant difference
of eosinophilic percentages in OVA groups with or
without alum (60% for A and 59% for B), which were
higher than ragweed groups (24% for C and 41% for
D). Conclusion: OVA induces higher IgE and
eosinophilic responses in BALB/c mice than ragweed.
Injections of natural antigens without alum are able to
induce IgE and airway inflammation responses. This
study was supported by The Hospital for Sick Children
Foundation (Toronto).
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